PEDIATRICS Vol. 83 No. 1 January 1989, pp. 146-147
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by NICKLAS, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by NICKLAS, R. A.

Theophylline, School Performance, and the Food and Drug Administration

RICHARD A. NICKLAS MD1

1 US Department of Health and Human Services, Food and Drug Administration, Rockville, MD 20857

Since an article by Rachelefsky and his colleagues was published in December 1986, there has been increased concern among children, their parents, and physicians regarding the potential for theophylline to produce behavioral changes that might adversely affect school performance.

Furakawa et al, in a pilot study published in March 1984 and a well-controlled study published in January 1988, concluded that such concern was justified, based on cognitive and behavioral findings in children treated with theophylline.